Evaluation of Sanofi Espoir Foundation’s My Child Matters Program

Did you know that in low- and middle-income countries (LMICs), only 20-30% of children with cancer survive? They are four times more likely to die than children in high-income countries, whose survival rates can be over 80%. This staggering disparity is due to factors including late diagnoses, treatment being abandoned because of distance or cost of treatment, or inappropriate treatment within weak health systems.

In 2021, the Sanofi Espoir Foundation (SEF) engaged HMST to review and assess its My Child Matters (MCM) program, established in 2005 in an effort to improve childhood cancer survival rates in LMICs. To date, the MCM has supported 80 small, locally-designed and locally-led projects in 60 countries, widely acknowledged as a unique approach in the pediatric oncology world.

Read more here about the MCM’s approach.

Like this article?